Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
andrew fire
biotech
boston
boston blog main
boston top stories
clinical study
clinical trials
craig mello
data
disease
enzyme
fda
gag
gene editing
genome editing
hereditary transthyretin amyloidosis
hunter syndrome
ids
inotersen
john maraganore
mps ii
mucopolysaccharidosis ii
new york blog main
new york top stories
nobel prize
onpattro
patisiran
pfizer
rna interference
san diego blog main
san diego top stories
san francisco
sandy macrae
What
landmark
2
×
medicine
2
×
afternoon
alnylam
alnylam’s
approved
benefit
drug
editing
fda
gene
gets
going
history
humans
isn't
little
making
morning
nasdaq
ok
onpattro
patisiran
pharmaceuticals
phase
reported
reports
results
rnai
sangamo
specifically
study
therapeutics
trial
u.s
Language
Current search:
landmark
×
medicine
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
